Projects 11718/19 (GPU, Core21) to FAH
Posted: Fri Aug 31, 2018 6:06 pm
Projects 11718 and 11719 now in FAH!
Stats:
11718:
# atoms: 50119
credit: 15047
k-factor: 0.75
timeout: 7d
deadline: 10d
precision: mixed
11719:
# atoms: 44691
credit: 12368
k-factor: 0.75
timeout: 7d
deadline: 10d
precision: mixed
The PRC2 complex is a therapeutic target for a number of cancers, currently undergoing clinical trials. It minimally consists of three proteins: EZH2, EED, and SUZ12. Its activity is regulated by a positive feedback loop, where the EED component reads already existing epigenetic marks and activates the EZH2 component to deposit more of them. Projects 11718-20 are looking at the dynamics of the three individual components of the complex (11718 - EED, 11719 - SUZ12). We are studying the allosteric mechanisms that control the functions of this molecular machine, as well as the potential for disrupting these mechanisms for the design of the next generation of inhibitors. Thanks folks!
Stats:
11718:
# atoms: 50119
credit: 15047
k-factor: 0.75
timeout: 7d
deadline: 10d
precision: mixed
11719:
# atoms: 44691
credit: 12368
k-factor: 0.75
timeout: 7d
deadline: 10d
precision: mixed
The PRC2 complex is a therapeutic target for a number of cancers, currently undergoing clinical trials. It minimally consists of three proteins: EZH2, EED, and SUZ12. Its activity is regulated by a positive feedback loop, where the EED component reads already existing epigenetic marks and activates the EZH2 component to deposit more of them. Projects 11718-20 are looking at the dynamics of the three individual components of the complex (11718 - EED, 11719 - SUZ12). We are studying the allosteric mechanisms that control the functions of this molecular machine, as well as the potential for disrupting these mechanisms for the design of the next generation of inhibitors. Thanks folks!